keyword
https://read.qxmd.com/read/38654621/molecular-engineering-and-morphology-control-of-covalent-organic-frameworks-for-enhancing-activity-of-metal-enzyme-cascade-catalysis
#21
JOURNAL ARTICLE
Hao Zhao, Jialin Zhang, Yunting Liu, Xinlong Liu, Li Ma, Liya Zhou, Jing Gao, Guanhua Liu, Xiaoyang Yue, Yanjun Jiang
Metal-enzyme integrated catalysts (MEICs) that combine metal and enzyme offer great potential for sustainable chemoenzymatic cascade catalysis. However, rational design and construction of optimal microenvironments and accessible active sites for metal and enzyme in individual nanostructures are necessary but still challenging. Herein, Pd nanoparticles (NPs) and Candida antarctica lipase B (CALB) are co-immobilized into the pores and surfaces of covalent organic frameworks (COFs) with tunable functional groups, affording Pd/COF-X/CALB (X = ONa, OH, OMe) MEICs...
April 23, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38654464/assessment-of-periodontal-health-status-in-patients-with-parkinson-s-disease-a-systematic-review-and-meta-analysis-of-cross-sectional-studies
#22
REVIEW
Krishna R Suryawanshi, Santosh Martande, Darshan N Kalal, Swathi Pv, Dharmarajan Gopalakrishnan, Anita Kulloli, Sharath Shetty, Shambhavi Thakur, Shreya Rokade, Jonathan Thomas
INTRODUCTION: Parkinson's disease (PKD) is neurodegenerative disorder marked by tremors, bradykinesia, muscle rigidity and reduction in precise hand movements which could lead to improper oral hygiene and Periodontal disease. Current systematic review aims to review existing literature and provide assessment of periodontal health in PKD patients through a meta-analysis METHODS: Review was performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines and registered in PROSPERO-CRD42023451700...
April 23, 2024: Special Care in Dentistry
https://read.qxmd.com/read/38654376/a-comprehensive-multivariate-analysis-of-the-center-of-pressure-during-quiet-standing-in-patients-with-parkinson-s-disease
#23
JOURNAL ARTICLE
Shintaro Fujii, Yusaku Takamura, Koki Ikuno, Shu Morioka, Noritaka Kawashima
BACKGROUND: We hypothesized that postural instability observed in individuals with Parkinson's disease (PD) can be classified as distinct subtypes based on comprehensive analyses of various evaluated parameters obtained from time-series of center of pressure (CoP) data during quiet standing. The aim of this study was to characterize the postural control patterns in PD patients by performing an exploratory factor analysis and subsequent cluster analysis using CoP time-series data during quiet standing...
April 23, 2024: Journal of Neuroengineering and Rehabilitation
https://read.qxmd.com/read/38654356/chemotherapy-elicited-extracellular-vesicle-cxcl1-from-dying-cells-promotes-triple-negative-breast-cancer-metastasis-by-activating-tam-pd-l1-signaling
#24
JOURNAL ARTICLE
Shengqi Wang, Jing Li, Shicui Hong, Neng Wang, Shang Xu, Bowen Yang, Yifeng Zheng, Juping Zhang, Bo Pan, Yudie Hu, Zhiyu Wang
BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and chemotherapy still serves as the cornerstone treatment functioning by inducing cytotoxic cell death. Notably, emerging evidence suggests that dying cell-released signals may induce cancer progression and metastasis by modulating the surrounding microenvironment. However, the underlying molecular mechanisms and targeting strategies are yet to be explored. METHODS: Apoptotic TNBC cells induced by paclitaxel or adriamycin treatment were sorted and their released extracellular vesicles (EV-dead) were isolated from the cell supernatants...
April 23, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38654302/emerging-therapeutic-frontiers-in-cancer-insights-into-posttranslational-modifications-of-pd-1-pd-l1-and-regulatory-pathways
#25
REVIEW
Rong Wang, Shiwei He, Jun Long, Yian Wang, Xianjie Jiang, Mingfen Chen, Jie Wang
The interaction between programmed cell death ligand 1 (PD-L1), which is expressed on the surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells, impedes the effective activation of tumor antigen-specific T cells, resulting in the evasion of tumor cells from immune-mediated killing. Blocking the PD-1/PD-L1 signaling pathway has been shown to be effective in preventing tumor immune evasion. PD-1/PD-L1 blocking antibodies have garnered significant attention in recent years within the field of tumor treatments, given the aforementioned mechanism...
April 23, 2024: Experimental Hematology & Oncology
https://read.qxmd.com/read/38654239/a-novel-tcga-validated-programmed-cell-death-related-signature-of-ovarian-cancer
#26
JOURNAL ARTICLE
Xintong Cai, Jie Lin, Li Liu, Jianfeng Zheng, Qinying Liu, Liyan Ji, Yang Sun
BACKGROUND: Ovarian cancer (OC) is a gynecological malignancy tumor with high recurrence and mortality rates. Programmed cell death (PCD) is an essential regulator in cancer metabolism, whose functions are still unknown in OC. Therefore, it is vital to determine the prognostic value and therapy response of PCD-related genes in OC. METHODS: By mining The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx) and Genecards databases, we constructed a prognostic PCD-related genes model and performed Kaplan-Meier (K-M) analysis and Receiver Operating Characteristic (ROC) curve for its predictive ability...
April 23, 2024: BMC Cancer
https://read.qxmd.com/read/38654110/improving-diagnostic-accuracy-of-identifying-gastric-cancer-patients-with-peritoneal-metastases-tumor-guided-cell-free-dna-analysis-of-peritoneal-fluid
#27
JOURNAL ARTICLE
Karen van der Sluis, Johanna W van Sandick, Marieke A Vollebergh, Jolanda M van Dieren, Niek Hugen, Koen J Hartemink, Alexander A F A Veenhof, Els Verhoeven, José G van den Berg, Petur Snaebjornsson, Michael Noe, Tom van Wezel, Mirjam C Boelens, Liudmila L Kodach
Detection of peritoneal dissemination (PD) in gastric cancer (GC) patients remains challenging. The feasibility of tumor-guided cell-free DNA (cfDNA) detection in prospectively collected peritoneal fluid (ascites and peritoneal lavage) was investigated and compared to conventional cytology in 28 patients. Besides conventional cytology, next generation sequencing was performed on primary tumor DNA and cell-free DNA from peritoneal fluid. Patients were retrospectively grouped into: a positive group (with PD) and a negative group (without PD)...
April 23, 2024: Oncogene
https://read.qxmd.com/read/38654003/protective-effect-of-increased-o-glcnac-cycling-against-6-ohda-induced-parkinson-s-disease-pathology
#28
JOURNAL ARTICLE
Dong Yeol Kim, Sang-Min Kim, Eun-Jeong Cho, Hyo-Bum Kwak, Inn-Oc Han
This study aimed to elucidate the role of O-GlcNAc cycling in 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease (PD)-like neurodegeneration and the underlying mechanisms. We observed dose-dependent downregulation of O-GlcNAcylation, accompanied by an increase in O-GlcNAcase following 6-OHDA treatment in both mouse brain and Neuro2a cells. Interestingly, elevating O-GlcNAcylation through glucosamine (GlcN) injection provided protection against PD pathogenesis induced by 6-OHDA. At the behavioral level, GlcN mitigated motor deficits induced by 6-OHDA, as determined using the pole, cylinder, and apomorphine rotation tests...
April 23, 2024: Cell Death & Disease
https://read.qxmd.com/read/38653982/peripheral-immune-cells-in-metastatic-breast-cancer-patients-display-a-systemic-immunosuppressed-signature-consistent-with-chronic-inflammation
#29
JOURNAL ARTICLE
Sudhir Kumar Chauhan, Claire Dunn, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Gjertrud Skorstad, Adam Sike, Bjørnar Gilje, Sunil Xavier Raj, Kanutte Huse, Bjørn Naume, Jon Amund Kyte
Immunotherapies blocking the PD-1/PD-L1 checkpoint show some efficacy in metastatic breast cancer (mBC) but are often hindered by immunosuppressive mechanisms. Understanding these mechanisms is crucial for personalized treatments, with peripheral blood monitoring representing a practical alternative to repeated biopsies. In the present study, we performed a comprehensive mass cytometry analysis of peripheral blood immune cells in 104 patients with HER2 negative mBC and 20 healthy donors (HD). We found that mBC patients had significantly elevated monocyte levels and reduced levels of CD4+ T cells and plasmacytoid dendritic cells, when compared to HD...
April 23, 2024: NPJ Breast Cancer
https://read.qxmd.com/read/38653897/racial-ethnic-disparities-discrimination-s-impact-on-health-related-quality-of-life-an-all-of-us-cancer-survivors-cross-sectional-study
#30
JOURNAL ARTICLE
Angel Arizpe, Carol Y Ochoa-Dominguez, Stephanie Navarro, Sue E Kim, Katelyn Queen, Trevor A Pickering, Albert J Farias
BACKGROUND: Discrimination is associated with worse mental and physical health outcomes. However, the associations among cancer survivors are limited. OBJECTIVE: We examined whether discrimination is associated with HRQoL and whether adjusting for it reduces racial/ethnic disparities in HRQoL among cancer survivors. METHODS: Cross-sectional data from adult cancer survivors who completed surveys on discrimination in the medical settings (DMS), everyday perceived discrimination (PD), and HRQoL in the "All of Us" Program from 2018 to 2022 were assessed...
April 23, 2024: Journal of Racial and Ethnic Health Disparities
https://read.qxmd.com/read/38653864/nivolumab-for-mismatch-repair-deficient-or-hypermutated-gynecologic-cancers-a-phase-2-trial-with-biomarker-analyses
#31
JOURNAL ARTICLE
Claire F Friedman, Beryl L Manning-Geist, Qin Zhou, Tara Soumerai, Aliya Holland, Arnaud Da Cruz Paula, Hunter Green, Melih Arda Ozsoy, Alexia Iasonos, Travis Hollmann, Mario M Leitao, Jennifer J Mueller, Vicky Makker, William P Tew, Roisin E O'Cearbhaill, Ying L Liu, Maria M Rubinstein, Tiffany Troso-Sandoval, Stuart M Lichtman, Alison Schram, Chrisann Kyi, Rachel N Grisham, Pamela Causa Andrieu, E John Wherry, Carol Aghajanian, Britta Weigelt, Martee L Hensley, Dmitriy Zamarin
Programmed death-1 (PD-1) inhibitors are approved for therapy of gynecologic cancers with DNA mismatch repair deficiency (dMMR), although predictors of response remain elusive. We conducted a single-arm phase 2 study of nivolumab in 35 patients with dMMR uterine or ovarian cancers. Co-primary endpoints included objective response rate (ORR) and progression-free survival at 24 weeks (PFS24). Secondary endpoints included overall survival (OS), disease control rate (DCR), duration of response (DOR) and safety...
April 23, 2024: Nature Medicine
https://read.qxmd.com/read/38653773/inflammatory-pathways-confer-resistance-to-chemoradiotherapy-in-anal-squamous-cell-carcinoma
#32
JOURNAL ARTICLE
D Martin, F Rödel, S Hehlgans, M Looso, P K Ziegler, M Fleischmann, M Diefenhardt, L Fries, G Kalinauskaite, I Tinhofer, D Zips, C Gani, C Rödel, E Fokas
Anal squamous cell carcinoma (ASCC) is associated with immunosuppression and infection with human papillomavirus (HPV). Response to standard chemoradiotherapy (CRT) varies considerably. A comprehensive molecular characterization of CRT resistance is lacking, and little is known about the interplay between tumor immune contexture, host immunity, and immunosuppressive and/or immune activating effects of CRT. Patients with localized ASCC, treated with CRT at three different sites of the German Cancer Consortium (DKTK) were included...
April 23, 2024: NPJ Precision Oncology
https://read.qxmd.com/read/38653714/an-interplay-between-ni-and-br%C3%A3-nsted-and-lewis-acid-sites-in-the-hydrodesulfurization-of-dibenzothiophene
#33
JOURNAL ARTICLE
Rodrigo Valderrama-Zapata, Julieth T García-Sánchez, Omar J Vargas-Montañez, Sergio A Rincón-Ortiz, Iván D Mora-Vergara, David Pérez-Martínez, Edgar M Morales-Valencia, Víctor Gabriel Baldovino Medrano
NiMo-S₂/γ-Al₂O₃ catalysts are commonly used in hydrotreating to enhance fossil fuel quality. The extensive research on these catalysts reveals a gap in understanding the role of Ni, often underestimated as an inactive sulfide phase or just a MoS₂ promoter. In this work, we focused on analyzing whether well-dispersed supported nickel nanoparticles can be active in the hydrodesulfurization of dibenzothiophene. We dispersed Ni by the Strong Electrostatic Adsorption (SEA) method over four supports with different types of acidity: silica (~ neutral acidity), γ-Al₂O₃ (Lewis acidity), H+-Y zeolite, and microporous-mesoporous H+-Y zeolite (both with Brønsted-Lewis acidity)...
April 23, 2024: Chemphyschem: a European Journal of Chemical Physics and Physical Chemistry
https://read.qxmd.com/read/38653603/corrigendum-to-synthesis-and-preclinical-evaluation-of-a-novel-molecular-probe-18-f-alf-nota-peg-2-asp-2-pdl1p-for-pet-imaging-of-pd-l1-positive-tumor-bioorgan-chem-145-2024-107193
#34
Penghui Sun, Chunwei Mo, Lu Bai, Meng Wang, Zihao Chen, Meilian Zhang, Yanjiang Han, Haoran Liang, Ganghua Tang
No abstract text is available yet for this article.
April 22, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38653580/interpretation-of-pd-l1-expression-in-gastric-cancer-summary-of-a-consensus-meeting-of-korean-gastrointestinal-pathologists
#35
REVIEW
Soomin Ahn, Yoonjin Kwak, Gui Young Kwon, Kyoung-Mee Kim, Moonsik Kim, Hyunki Kim, Young Soo Park, Hyeon Jeong Oh, Kyoungyul Lee, Sung Hak Lee, Hye Seung Lee
Nivolumab plus chemotherapy in the first-line setting has demonstrated clinical efficacy in patients with human epidermal growth factor receptor 2-negative advanced or metastatic gastric cancer, and is currently indicated as a standard treatment. Programmed death-ligand 1 (PD-L1) expression is an important biomarker for predicting response to anti-programmed death 1/PD-L1 agents in several solid tumors, including gastric cancer. In the CheckMate-649 trial, significant clinical improvements were observed in patients with PD-L1 combined positive score (CPS) ≥ 5, determined using the 28-8 pharmDx assay...
April 25, 2024: Journal of Pathology and Translational Medicine
https://read.qxmd.com/read/38653508/epirubicin-for-the-treatment-of-sepsis-and-septic-shock-epos-1-study-protocol-for-a-randomised-placebo-controlled-phase-iia-dose-escalation-trial
#36
RANDOMIZED CONTROLLED TRIAL
Daniel Thomas-Rüddel, Michael Bauer, Luís Ferreira Moita, Christiane Helbig, Peter Schlattmann, Johannes Ehler, Tim Rahmel, Patrick Meybohm, Matthias Gründling, Heiko Schenk, Thomas Köcher, Frank M Brunkhorst, Markus Gräler, Ann-Julika Heger, Sebastian Weis
INTRODUCTION: Sepsis remains the major cause of death among hospitalised patients in intensive care. While targeting sepsis-causing pathogens with source control or antimicrobials has had a dramatic impact on morbidity and mortality of sepsis patients, this strategy remains insufficient for about one-third of the affected individuals who succumb. Pharmacological targeting of mechanisms that reduce sepsis-defining organ dysfunction may be beneficial. When given at low doses, the anthracycline epirubicin promotes tissue damage control and lessens the severity of sepsis independently of the host-pathogen load by conferring disease tolerance to infection...
April 22, 2024: BMJ Open
https://read.qxmd.com/read/38653485/fundamentals-of-deep-brain-stimulation-for-parkinson-s-disease-in-clinical-practice-part-1
#37
REVIEW
Camila Henriques de Aquino, Mariana Moscovich, Murilo Martinez Marinho, Lorena Broseghini Barcelos, André C Felício, Matthew Halverson, Clement Hamani, Henrique Ballalai Ferraz, Renato Puppi Munhoz
Deep brain stimulation (DBS) is recognized as an established therapy for Parkinson's disease (PD) and other movement disorders in the light of the developments seen over the past three decades. Long-term efficacy is established for PD with documented improvement in the cardinal motor symptoms of PD and levodopa-induced complications, such as motor fluctuations and dyskinesias. Timing of patient selection is crucial to obtain optimal benefits from DBS therapy, before PD complications become irreversible. The objective of this first part review is to examine the fundamental concepts of DBS for PD in clinical practice, discussing the historical aspects, patient selection, potential effects of DBS on motor and non-motor symptoms, and the practical management of patients after surgery...
April 2024: Arquivos de Neuro-psiquiatria
https://read.qxmd.com/read/38653449/early-erythroferrone-levels-can-predict-the-long-term-haemoglobin-responses-to-erythropoiesis-stimulating-agents
#38
JOURNAL ARTICLE
Peng Xu, Raymond S M Wong, Xiaoyu Yan
BACKGROUND AND PURPOSE: Our previous study reported that erythroferrone (ERFE), a newly identified hormone produced by erythroblasts, responded to recombinant human erythropoietin (rHuEPO) sensitively but its dynamics was complicated by double peaks and circadian rhythm. This study intends to elucidate the underlying mechanisms for the double peaks of ERFE dynamics and further determine whether early ERFE measurements can predict haemoglobin responses to rHuEPO. EXPERIMENTAL APPROACH: By using the purified recombinant rat ERFE protein and investigating its deposition in rats, the production of ERFE was deconvoluted...
April 23, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38653380/durvalumab-impacts-progression-free-survival-while-high-dose-radiation-66%C3%A2-gy-improves-local-control-without-excess-toxicity-in-unresectable-nsclc-stage-iii-real-world-data-from-the-austrian-radio-oncological-lung-cancer-study-association-registry-allstar
#39
JOURNAL ARTICLE
Franz Zehentmayr, Petra Feurstein, Elvis Ruznic, Brigitte Langer, Brane Grambozov, Marisa Klebermass, Herbert Hüpfel, Johann Feichtinger, Danijela Minasch, Martin Heilmann, Barbara Breitfelder, Claudia Steffal, Gisela Gastinger-Grass, Karoline Kirchhammer, Margit Kazil, Heidi Stranzl, Karin Dieckmann
BACKGROUND: Chemo-radioimmunotherapy with total radiation doses of 60-66 Gy in 2 Gy fractions is the standard of care for non-small cell lung cancer (NSCLC) UICC stage III. The Austrian radio-oncological lung cancer study association registry (ALLSTAR) is a prospective multicentre registry intended to document clinical practice at the beginning of the Durvalumab era. PATIENTS AND METHODS: Patients were eligible if they had pathologically verified unresectable NSCLC stage III with a curative treatment option...
April 21, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38652990/incidence-of-microplastic-contamination-in-fishes-of-the-ramsar-wetland-loktak-the-world-s-only-floating-lake-from-the-indian-himalayan-region
#40
JOURNAL ARTICLE
Pallabi Borah, Naphibaniarlin Kshiar, Demsai Reang, Arun Jyoti Nath, Kushal Kumar Baruah
Microplastics are ubiquitous, and their widespread prevalence in the ecosphere has generated concerns about their potential effects on terrestrial and aquatic organisms. However, studies pertaining to ecologically sensitive freshwater ecosystems, such as Ramsar wetlands, is scarce. Therefore, the study was conducted in Loktak, the world's only floating lake, and one of the largest wetland in the Indian Himalayan region. The wetland's degradation and pollution have resulted its inclusion in the Montreux Record, underscoring the need for studying this eco-sensitive freshwater system...
April 22, 2024: Journal of Environmental Management
keyword
keyword
19433
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.